BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Feb 10, 15:52Prev. Close
96.49
Open Price
99.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Par Drugs & Chemicals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 112.96 | 106.73 | 107.66 | 83.98 | 68.19 | |
| Less: Excise/Sevice Tax/Other Levies | 12.42 | 11.62 | 12.57 | 9.78 | 8.32 | |
| Revenue From Operations [Net] | 100.55 | 95.11 | 95.10 | 74.20 | 59.88 | |
| Total Operating Revenues | 100.97 | 95.64 | 95.75 | 75.07 | 60.75 | |
| Other Income | 2.15 | 0.24 | 0.24 | 0.18 | 0.19 | |
| Total Revenue | 103.12 | 95.88 | 95.99 | 75.26 | 60.94 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 39.41 | 33.32 | 41.03 | 29.61 | 22.09 | |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 29.65 | 25.09 | 26.08 | 21.04 | 15.56 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -1.28 | 0.47 | -0.70 | -0.79 | -0.21 | |
| Employee Benefit Expenses | 5.85 | 5.50 | 4.89 | 4.10 | 3.98 | |
| Finance Costs | 0.08 | 0.11 | 0.13 | 0.45 | 0.64 | |
| Depreciation And Amortisation Expenses | 3.65 | 3.44 | 3.23 | 3.28 | 2.82 | |
| Other Expenses | 7.84 | 8.44 | 6.25 | 4.85 | 3.32 | |
| Total Expenses | 85.20 | 76.37 | 80.91 | 62.56 | 48.20 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 17.92 | 19.52 | 15.08 | 12.70 | 12.74 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 17.92 | 19.52 | 15.08 | 12.70 | 12.74 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 4.53 | 4.98 | 3.80 | 3.35 | 3.36 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 0.04 | 0.04 | -0.05 | 0.14 | -0.25 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 4.57 | 5.02 | 3.75 | 3.49 | 3.11 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 13.36 | 14.50 | 11.33 | 9.21 | 9.63 | |
| Profit/Loss From Continuing Operations | 13.36 | 14.50 | 11.33 | 9.21 | 11.61 | |
| Profit/Loss For The Period | 13.36 | 14.50 | 11.33 | 9.21 | 11.61 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 10.86 | 11.78 | 9.21 | 7.49 | 18.87 | |
| Diluted EPS (Rs.) | 10.86 | 11.78 | 9.21 | 7.49 | 18.87 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 33.32 | 41.03 | 29.61 | 22.09 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 1.54 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 13.00 | 0.00 |
27.11.2025
Par Drugs Standalone September 2025 Net Sales at Rs 28.66 crore, down 17.31% Y-o-Y
22.08.2025
Par Drugs Standalone June 2025 Net Sales at Rs 26.05 crore, up 15.22% Y-o-Y
12.05.2025
Par Drugs Standalone March 2025 Net Sales at Rs 22.33 crore, down 2.14% Y-o-Y
23.10.2024
Par Drugs Standalone September 2024 Net Sales at Rs 34.66 crore, up 33.88% Y-o-Y
15.03.2018
24.04.2017
24.04.2017
20.04.2017